Dermata Therapeutics Inc (DRMA)

NASDAQ
0.54
+0.01(+1.68%)
After Hours
0.58
+0.03(+6.48%)
- Real-time Data
  • Volume:
    75,365
  • Day's Range:
    0.51 - 0.58
  • 52 wk Range:
    0.44 - 6.95
Unusual Post-Market activity

Post-market activity occurs after regular market hours and can be used to judge market strength and direction. Post-market trading has some risk because of lower liquidity and more volatility than regular sessions.

DRMA Overview

Prev. Close
0.53
Day's Range
0.51-0.58
Revenue
-
Open
0.51
52 wk Range
0.44-6.95
EPS
-1.5
Volume
75,365
Market Cap
5.46M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,563,701
P/E Ratio
-0.425
Beta
2.12
1-Year Change
-89.33%
Shares Outstanding
10,102,214
Next Earnings Date
Nov 14, 2022
What is your sentiment on Dermata Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Dermata Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Dermata Therapeutics Inc Company Profile

Dermata Therapeutics Inc Company Profile

Employees
8

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company’s lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.

Read More

Analyst Price Target

Average9.00 (+1566.67% Upside)
High14
Low4
Price0.54
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Sell
SummaryStrong SellSellStrong SellStrong SellStrong Sell